Skip to content

Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Qualitative OCT Image Grading Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03912584
Enrollment
10
Registered
2019-04-11
Start date
2019-04-29
Completion date
2019-04-30
Last updated
2022-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The study evaluates the image quality between two OCT devices.

Detailed description

The objective of this study is to collect OCT scans to compare the qualitative B scan images produced by the P200TxE to the P200TE device in glaucoma subjects.

Interventions

DEVICEP200TE

The P200TE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.

DEVICEP200TxE

The P200TxE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.

Sponsors

Optos, PLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed; * Subjects who can follow the instructions by the clinical staff at the clinical site, * Subjects who agree to participate in the study; * Subjects who have been diagnosed with glaucoma in the study eye as confirmed by the investigator;

Exclusion criteria

* Subjects unable to tolerate ophthalmic imaging; * Subjects with ocular media not sufficiently clear to obtain acceptable OCT images; * Subjects with any clinically significant ocular pathology except glaucoma, as determined by self-report and/or investigator assessment on the day of the study visit; * Subjects who are not reliably tested with at least one Humphrey Field Analyzer (HFA) visual field (24-2 or 30-2, white on white) measured on the day of the study visit or within the previous year from the study visit, defined as fixation losses \> 20% or false positives \> 33%, or false negatives \> 33%; * Subjects with history of dementia or multiple sclerosis

Design outcomes

Primary

MeasureTime frameDescription
Qualitative B-Scan Assessment1 day (start: April 29, 2019 - completed: April 30, 2019)Scores will be based on a 4 point grading scale (0 to 3), with 0 corresponding to failure, 1 is poor, 2 is fair, and 3 is good. The four point scale is defined as follows: 0 indicates the scan is a failure, and contains no clinically useful information. No relevant structures are visible in the scan. 1. indicates the condition of the structure or feature being assessed is poor, and it contains very limited clinical utility. 2. indicates the condition of the structure or feature being assessed is fair or average. It contains some useful clinical information and therefore provides adequate clinical utility. 3. indicates the condition of the structure or feature being assessed is good. It contains useful clinical information. The clinical utility is high or good.

Secondary

MeasureTime frameDescription
Number of Participants With Adverse Events1 dayAnalysis of safety will be assessed through adverse events reported by the site and documented on each subject's case report form. No AEs were recorded during this study.

Countries

United States

Participant flow

Participants by arm

ArmCount
Optical Coherence Tomographer
P200TE: The P200TE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device. P200TxE: The P200TxE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.
10
Total10

Baseline characteristics

CharacteristicOptical Coherence Tomographer
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
5 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Glaucoma in Subject eye10 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
10 participants
Sex/Gender, Customized
Male or Female
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Qualitative B-Scan Assessment

Scores will be based on a 4 point grading scale (0 to 3), with 0 corresponding to failure, 1 is poor, 2 is fair, and 3 is good. The four point scale is defined as follows: 0 indicates the scan is a failure, and contains no clinically useful information. No relevant structures are visible in the scan. 1. indicates the condition of the structure or feature being assessed is poor, and it contains very limited clinical utility. 2. indicates the condition of the structure or feature being assessed is fair or average. It contains some useful clinical information and therefore provides adequate clinical utility. 3. indicates the condition of the structure or feature being assessed is good. It contains useful clinical information. The clinical utility is high or good.

Time frame: 1 day (start: April 29, 2019 - completed: April 30, 2019)

Population: The average score (0-3) for clinical utility and clinical quality for the P200TxE does not apply to P200TE scans, and the average score (0-3) for clinical utility and clinical quality for the P200TE does not apply to P200TxE scans. 10 subjects were imaged in total, however clinical utility and quality were measured separately for the three outcomes described below (1. Indy posterior scans, 2. Indy peripheral scans, 3. Monaco scans).

ArmMeasureGroupValue (MEAN)Dispersion
Optical Coherence Tomographer - P200TEQualitative B-Scan AssessmentAverage score (0-3) for clinical utility and clinical quality Monaco (P200TE) scans2.08 Mean score on a scale (0-3)Standard Deviation 0.64
Optical Coherence Tomographer - P200TxEQualitative B-Scan AssessmentAverage score (0-3) for clinical utility and clinical quality Indy (P200TxE) Posterior scans2.78 Mean score on a scale (0-3)Standard Deviation 0.45
Optical Coherence Tomographer - P200TxEQualitative B-Scan AssessmentAverage score (0-3) for clinical utility and clinical quality Indy (P200TxE) Peripheral scans2.77 Mean score on a scale (0-3)Standard Deviation 0.46
Secondary

Number of Participants With Adverse Events

Analysis of safety will be assessed through adverse events reported by the site and documented on each subject's case report form. No AEs were recorded during this study.

Time frame: 1 day

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Optical Coherence Tomographer - P200TENumber of Participants With Adverse Events0 Participants
Optical Coherence Tomographer - P200TxENumber of Participants With Adverse Events0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026